CEP-40125
CEP-40125, also known as RXDX-107, is a DNA alkylating drug potentially for the treatment of advanced solid tumours.
| Chemical | |
|---|---|
| CAS Num | 1456608-94-8 |
| Chemical Formula | C28H45Cl2N3O2 |
| Molecular Weight | 526.587 |
| IUPAC Chemical Name | dodecyl 4-(5-(bis(2-chloroethyl)amino)-1-methyl-1H-benzo[d]imidazol-2-yl)butanoate |
| Exact Mass | 525.2889 |
| Elemental Analysis | C, 63.87; H, 8.61; Cl, 13.46; N, 7.98; O, 6.08 |
| Synonym | CEP-40125; CEP-40125; CEP-40125; RXDX-107; RXDX-107; RXDX-107 |
| Solubility | Soluble in DMSO |
| SMILES Code | O=C(OCCCCCCCCCCCC)CCCC1=NC2=CC(N(CCCl)CCCl)=CC=C2N1C |
| Biological | |
| Targets and Effects | N/A |
| Pathways | alkylating agent |
| Physical | |
| Appearance | Solid powder |
| Purity | >98% (or refer to the Certificate of Analysis) |
| Shipping Condition | Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs. |
| Storage Condition | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
| Shelf Life | >2 years if stored properly |
Mailing Address
Anba Pharma Company
3-H Gill Street, Suite 300
Woburn, MA 01801
United State
Our Contact Info.
Tel: 1+610-883-0668
Email: sales@AnbaPharma.com